Two human myeloma cell lines, amylase-producing KMS-12-PE and amylase-non-producing KMS-12-BM, were established from a patient, having the same chromosome marker, t(11;14)(q13;q32).

British Journal of Haematology
T OhtsukiM Namba

Abstract

Two human myeloma cell lines, KMS-12-PE and KMS-12-BM, were established from a 64-year-old woman with a non-producing type of multiple myeloma. The KMS-12-PE line originated from the pleural effusion and the KMS-12-BM from the bone marrow. These two lines showed the same chromosome marker, t(11:14)(q13:q32). However, their phenotypes of surface markers differed from each other. KMS-12-BM cells were positive to CD20, CD38 and PCA-1. showing the plasmacytoid (immature plasma cell) stage of B-cell differentiation, while KMS-12-PE cells were positive to CD38 and PCA-1, but not to CD20, indicating the terminal differentiated stage of B-cells. As seen in the pleural effusion of the patient. KMS-12-PE cells ectopically produced a salivary type of amylase, but KMS-12-BM cells did not. Interestingly, the chromosome abnormality of del(1)(p22----pter) near the region of 1p21, where the amylase gene was assigned, was noticed in as many as 76% of KMS-12-PE cells.

References

Sep 15, 1987·International Journal of Cancer. Journal International Du Cancer·A DonelliU Torelli
Jul 1, 1988·British Journal of Haematology·J LohmeyerH Pralle
Dec 15, 1987·International Journal of Cancer. Journal International Du Cancer·H JernbergK Nilsson
Jun 15, 1987·International Journal of Cancer. Journal International Du Cancer·H JernbergK Nilsson
Aug 15, 1985·International Journal of Cancer. Journal International Du Cancer·S KatagiriS Tarui
May 1, 1973·International Journal of Cancer. Journal International Du Cancer·B M Reedman, G Klein
Aug 1, 1967·Proceedings of the Society for Experimental Biology and Medicine·Y MatsuokaD Pressman
Nov 1, 1983·Proceedings of the National Academy of Sciences of the United States of America·B U ZabelT B Shows
Apr 1, 1984·Cancer Genetics and Cytogenetics·H Van den BergheJ P Vaerman
May 28, 1982·Science·A KarpasD Swirsky
May 15, 1982·International Journal of Cancer. Journal International Du Cancer·A TogawaM Namba
May 1, 1982·Nihon Ketsueki Gakkai zasshi : journal of Japan Haematological Society·A TogawaM Namba

❮ Previous
Next ❯

Citations

Dec 1, 1994·Genes, Chromosomes & Cancer·S Galiègue-ZouitinaJ P Kerckaert
Jan 16, 1995·Clinica Chimica Acta; International Journal of Clinical Chemistry·T MoriyamaH Ikeda
Nov 25, 1998·British Journal of Haematology·T OtsukiA Ueki
Feb 1, 1991·British Journal of Haematology·T OhtsukiM Namba
May 1, 1992·British Journal of Haematology·M SawamuraJ Tsuchiya
Jan 17, 2013·British Journal of Cancer·S FujiwaraH Hata
Aug 1, 1993·Leukemia & Lymphoma·Y ShimamotoM Yamaguchi
Oct 29, 2002·Leukemia & Lymphoma·Marco SagristaniAngelo Tirelli
Sep 19, 2006·Clinica Chimica Acta; International Journal of Clinical Chemistry·Masahiko ShigemuraMasaharu Nishimura
Dec 23, 2014·International Journal of Oncology·Naoko WadaHiroyuki Hata
Jan 21, 2015·Bioorganic & Medicinal Chemistry Letters·Ryan P WurzAndrew S Tasker
Sep 20, 2007·Leukemia·D Dingli, S J Russell
Apr 3, 2001·American Journal of Hematology·N HatakeyamaH Taguchi
Apr 26, 2006·Experimental Biology and Medicine·Takemi OtsukiTakumi Kishimoto
Apr 5, 2018·Oncology Letters·Eri FujiiHiroyuki Hata
May 1, 1994·Clinical and Experimental Immunology·H HataK Takatsuki
Jun 17, 1998·International Journal of Cancer. Journal International Du Cancer·Y HosokawaM Seto

❮ Previous
Next ❯

Related Concepts

Related Feeds

B cell Differentiation

Depending on the signal received through the B cell receptor and other receptors, B cells differentiate into follicular or marginal zone B cells. Here is the latest research pertaining to this differentiation process.